Therapy Areas: Diabetes
EKF Diagnostics acquires Beep Insights technology to expand sports performance offering
13 April 2026 - Life sciences company EKF Diagnostics Holdings plc (AIM: EKF) has acquired technology assets from Sweden-based Beep Insights AB, including its iOS and Android application designed for ...
Apotex's generic Ozempic (Semaglutide Injection) receives US FDA tentative approval
13 April 2026 - Canadian pharmaceutical company Apotex Inc announced on Friday that its US subsidiary Apotex Corp has received the first US Food and Drug Administration (FDA) tentative approval for it...
Lupin's Dapagliflozin Tablets launched in US market
13 April 2026 - India-based global pharmaceutical company Lupin Limited (BSE:500257) (NSE:LUPIN) announced on Friday the launch of Dapagliflozin Tablets, 5 mg and 10 mg, in the United States.Lupin...
Eli Lilly launches Foundayo weight‑loss pill in the US
...
Lupin's Dapagliflozin Tablets receive US regulatory approval
8 April 2026 - India-based global pharmaceutical company Lupin Limited (BSE:500257) (NSE:LUPIN) announced on Tuesday that it has received approval from the US Food and Drug Administration (FDA) for it...
Caliway to present preclinical data on CBL-514 in combination with GLP-1R therapy at ADA 2026 Scientific Sessions
2 April 2026 - Caliway Biopharmaceuticals (TWSE:6919), a Taiwan-based clinical-stage biopharmaceutical company, announced on Thursday that the latest preclinical data on its first-in-class large-area ...